跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/EUCTR2005-004250-28-BE
EUCTR2005-004250-28-BE进行中（未招募）不适用

A MULTICENTER, RANDOMIZED, OPEN-LABEL COMPARISON OF THE SAFETYAND EFFICACY OF TIGECYCLINE WITH THAT OF AMPICILLIN-SULBACTAMOR AMOXICILLIN-CLAVULANATE TO TREAT COMPLICATED SKIN AND SKINSTRUCTURE INFECTIONS.

Wyeth Pharmaceuticals, Inc.0 个研究点开始时间: 2006年8月31日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症
相关药物

试验速览

阶段
不适用
状态
进行中（未招募）
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

相似试验

进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN-LABEL COMPARISON OF THE SAFETYAND EFFICACY OF TIGECYCLINE WITH THAT OF AMPICILLIN-SULBACTAMOR AMOXICILLIN-CLAVULANATE TO TREAT COMPLICATED SKIN AND SKINSTRUCTURE INFECTIONS.COMPLICATED SKIN AND SKIN STRUCTURE INFECTIO
EUCTR2005-004250-28-PTWyeth Pharmaceuticals, Inc.500
进行中（未招募）
1 期
A MULTICENTER, RANDOMIZED, OPEN-LABEL COMPARISON OF THE SAFETY AND EFFICACY OF TIGECYCLINE WITH THAT OF AMPICILLIN-SULBACTAM OR AMOXICILLIN-CLAVULANATE TO TREAT COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS.COMPLICATED SKIN AND SKIN STRUCTURE INFECTIO
EUCTR2005-004250-28-GBWyeth Pharmaceuticals, Inc.500
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN-LABEL COMPARISON OF THE SAFETYAND EFFICACY OF TIGECYCLINE WITH THAT OF AMPICILLIN-SULBACTAMOR AMOXICILLIN-CLAVULANATE TO TREAT COMPLICATED SKIN AND SKINSTRUCTURE INFECTIONS.COMPLICATED SKIN AND SKIN STRUCTURE INFECTIO
EUCTR2005-004250-28-DEWyeth Pharmaceuticals, Inc.500
进行中（未招募）
1 期
A MULTICENTER, RANDOMIZED, OPEN-LABEL COMPARISON OF THE SAFETYAND EFFICACY OF TIGECYCLINE WITH THAT OF AMPICILLIN-SULBACTAMOR AMOXICILLIN-CLAVULANATE TO TREAT COMPLICATED SKIN AND SKINSTRUCTURE INFECTIONS.COMPLICATED SKIN AND SKIN STRUCTURE INFECTIO
EUCTR2005-004250-28-FRWyeth Pharmaceuticals, Inc.500
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN-LABEL COMPARISON OF THE SAFETY AND EFFICACY OF TIGECYCLINE WITH THAT OF AMPICILLIN-SULBACTAM OR AMOXICILLIN-CLAVULANATE TO TREAT COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS - NDComplicated skin and skin structure infection (cSSSI).MedDRA version: 6.1Level: HLTClassification code 10040788
EUCTR2005-004250-28-ITWyeth Pharmaceuticals, Inc.500